Prediction of contralateral progression in patients with bilateral nonhemorrhagic moyamoya disease following unilateral revascularization surgery

医学 烟雾病 外科 血运重建 内科学 心肌梗塞
作者
Chang Hwan Pang,Sang Hyo Lee,Taewon Choi,Hyoung Soo Byoun,Young-Deok Kim,Seung Pil Ban,Jae Seung Bang,O-Ki Kwon,Chang Wan Oh,Si Un Lee
出处
期刊:Journal of Neurosurgery [American Association of Neurological Surgeons]
卷期号:: 1-8 被引量:2
标识
DOI:10.3171/2024.5.jns2411
摘要

OBJECTIVE This study was designed to identify predictive factors associated with substantial contralateral progression in adult patients with bilateral nonhemorrhagic moyamoya disease (MMD) who undergo revascularization surgery (RS) on one hemisphere. METHODS The authors retrospectively analyzed 174 contralateral hemispheres of patients with bilateral nonhemorrhagic MMD (non-hMMD) who underwent RS on one side. The primary endpoint was defined as substantial contralateral progression requiring additional RS 6 months after the initial RS. The annual risk and predictive factors for contralateral progression were also analyzed. RESULTS Of 174 patients included in the study, 57 (32.8%) experienced contralateral progression over a mean follow-up of 45.3 ± 31.6 months (range 12–196 months). The annual risk for contralateral progression after initial unilateral RS was 7.7% per person-year. Multivariable analysis revealed that age (HR 0.967, 95% CI 0.944–0.992; p = 0.009) and a BMI ≥ 25 (HR 1.946, 95% CI 1.126–3.362; p = 0.017) were significant predictors of contralateral progression. Specifically, the annual risk of contralateral progression was 12.1% in the higher BMI (≥ 25) group and 4.0% in the lower BMI (< 25) group per person-year. CONCLUSIONS The study revealed a 7.7% per person-year rate of contralateral progression in patients with bilateral non-hMMD following unilateral RS. Younger age and a BMI ≥ 25 were identified as significant risk factors. For these patients, careful weight management and the use of antilipid agents may be crucial strategies for reducing the risk of contralateral progression after unilateral RS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刘雪完成签到 ,获得积分10
1秒前
完美梨愁完成签到 ,获得积分10
1秒前
yyy完成签到,获得积分10
1秒前
李健的粉丝团团长应助zzzz采纳,获得10
2秒前
Dudidu完成签到,获得积分10
2秒前
一颗大树完成签到,获得积分10
3秒前
潇洒的浩然完成签到,获得积分10
4秒前
比比谁的速度快应助曾珍采纳,获得50
4秒前
6秒前
NiNi完成签到,获得积分10
7秒前
Ther完成签到,获得积分20
8秒前
傲娇白安完成签到,获得积分10
9秒前
9秒前
甜蜜的荟完成签到,获得积分20
10秒前
婷儿完成签到,获得积分10
10秒前
牛牛发布了新的文献求助10
10秒前
Hoper完成签到,获得积分10
10秒前
张曰淼完成签到,获得积分10
11秒前
共渡完成签到,获得积分10
13秒前
凉白开完成签到 ,获得积分10
14秒前
跳跃的太君完成签到,获得积分10
15秒前
小猪发布了新的文献求助10
15秒前
独特问夏完成签到,获得积分10
16秒前
16秒前
17秒前
魔幻蓉完成签到,获得积分10
17秒前
杠赛来完成签到,获得积分10
17秒前
ccy完成签到 ,获得积分10
18秒前
Ch185完成签到,获得积分10
19秒前
欣喜的复天完成签到,获得积分10
21秒前
摸鱼校尉完成签到,获得积分0
21秒前
双儿完成签到,获得积分10
21秒前
顺利毕业完成签到 ,获得积分10
21秒前
儒雅的焦完成签到 ,获得积分10
21秒前
小何完成签到 ,获得积分10
21秒前
23秒前
24秒前
小曾应助张绪帆采纳,获得10
24秒前
麻麻薯完成签到 ,获得积分10
25秒前
25秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038368
求助须知:如何正确求助?哪些是违规求助? 3576068
关于积分的说明 11374313
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029